Cargando…

The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma

BACKGROUND: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of treatments that have not been studied in head-to-head trials; however, relative treatment effects for all interventions can only be derived where available evidence forms a connected network. Head-to-he...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Susanne, Maguire, Áine, Morris, James, Ruggeri, Kai, Haller, Elisa, Kuhn, Isla, Leahy, Joy, Homer, Natalia, Khan, Ayesha, Bowden, Jack, Buchanan, Vanessa, O’Dwyer, Michael, Cook, Gordon, Walsh, Cathal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022299/
https://www.ncbi.nlm.nih.gov/pubmed/29954322
http://dx.doi.org/10.1186/s12874-018-0509-7
_version_ 1783335649441480704
author Schmitz, Susanne
Maguire, Áine
Morris, James
Ruggeri, Kai
Haller, Elisa
Kuhn, Isla
Leahy, Joy
Homer, Natalia
Khan, Ayesha
Bowden, Jack
Buchanan, Vanessa
O’Dwyer, Michael
Cook, Gordon
Walsh, Cathal
author_facet Schmitz, Susanne
Maguire, Áine
Morris, James
Ruggeri, Kai
Haller, Elisa
Kuhn, Isla
Leahy, Joy
Homer, Natalia
Khan, Ayesha
Bowden, Jack
Buchanan, Vanessa
O’Dwyer, Michael
Cook, Gordon
Walsh, Cathal
author_sort Schmitz, Susanne
collection PubMed
description BACKGROUND: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of treatments that have not been studied in head-to-head trials; however, relative treatment effects for all interventions can only be derived where available evidence forms a connected network. Head-to-head evidence is limited in many disease areas, regularly resulting in disconnected evidence structures where a large number of treatments are available. This is also the case in the evidence of treatments for relapsed or refractory multiple myeloma. METHODS: Randomised controlled trials (RCTs) identified in a systematic literature review form two disconnected evidence networks. Standard Bayesian NMA models are fitted to obtain estimates of relative effects within each network. Observational evidence was identified to fill the evidence gap. Single armed trials are matched to act as each other’s control group based on a distance metric derived from covariate information. Uncertainty resulting from including this evidence is incorporated by analysing the space of possible matches. RESULTS: Twenty five randomised controlled trials form two disconnected evidence networks; 12 single armed observational studies are considered for bridging between the networks. Five matches are selected to bridge between the networks. While significant variation in the ranking is observed, daratumumab in combination with dexamethasone and either lenalidomide or bortezomib, as well as triple therapy of carfilzomib, ixazomib and elozumatab, in combination with lenalidomide and dexamethasone, show the highest effects on progression free survival, on average. CONCLUSIONS: The analysis shows how observational data can be used to fill gaps in the existing networks of RCT evidence; allowing for the indirect comparison of a large number of treatments, which could not be compared otherwise. Additional uncertainty is accounted for by scenario analyses reducing the risk of over confidence in interpretation of results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-018-0509-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6022299
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60222992018-07-09 The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma Schmitz, Susanne Maguire, Áine Morris, James Ruggeri, Kai Haller, Elisa Kuhn, Isla Leahy, Joy Homer, Natalia Khan, Ayesha Bowden, Jack Buchanan, Vanessa O’Dwyer, Michael Cook, Gordon Walsh, Cathal BMC Med Res Methodol Research Article BACKGROUND: Network meta-analysis (NMA) allows for the estimation of comparative effectiveness of treatments that have not been studied in head-to-head trials; however, relative treatment effects for all interventions can only be derived where available evidence forms a connected network. Head-to-head evidence is limited in many disease areas, regularly resulting in disconnected evidence structures where a large number of treatments are available. This is also the case in the evidence of treatments for relapsed or refractory multiple myeloma. METHODS: Randomised controlled trials (RCTs) identified in a systematic literature review form two disconnected evidence networks. Standard Bayesian NMA models are fitted to obtain estimates of relative effects within each network. Observational evidence was identified to fill the evidence gap. Single armed trials are matched to act as each other’s control group based on a distance metric derived from covariate information. Uncertainty resulting from including this evidence is incorporated by analysing the space of possible matches. RESULTS: Twenty five randomised controlled trials form two disconnected evidence networks; 12 single armed observational studies are considered for bridging between the networks. Five matches are selected to bridge between the networks. While significant variation in the ranking is observed, daratumumab in combination with dexamethasone and either lenalidomide or bortezomib, as well as triple therapy of carfilzomib, ixazomib and elozumatab, in combination with lenalidomide and dexamethasone, show the highest effects on progression free survival, on average. CONCLUSIONS: The analysis shows how observational data can be used to fill gaps in the existing networks of RCT evidence; allowing for the indirect comparison of a large number of treatments, which could not be compared otherwise. Additional uncertainty is accounted for by scenario analyses reducing the risk of over confidence in interpretation of results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-018-0509-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-28 /pmc/articles/PMC6022299/ /pubmed/29954322 http://dx.doi.org/10.1186/s12874-018-0509-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schmitz, Susanne
Maguire, Áine
Morris, James
Ruggeri, Kai
Haller, Elisa
Kuhn, Isla
Leahy, Joy
Homer, Natalia
Khan, Ayesha
Bowden, Jack
Buchanan, Vanessa
O’Dwyer, Michael
Cook, Gordon
Walsh, Cathal
The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title_full The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title_fullStr The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title_full_unstemmed The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title_short The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
title_sort use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022299/
https://www.ncbi.nlm.nih.gov/pubmed/29954322
http://dx.doi.org/10.1186/s12874-018-0509-7
work_keys_str_mv AT schmitzsusanne theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT maguireaine theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT morrisjames theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT ruggerikai theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT hallerelisa theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT kuhnisla theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT leahyjoy theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT homernatalia theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT khanayesha theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT bowdenjack theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT buchananvanessa theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT odwyermichael theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT cookgordon theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT walshcathal theuseofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT schmitzsusanne useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT maguireaine useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT morrisjames useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT ruggerikai useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT hallerelisa useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT kuhnisla useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT leahyjoy useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT homernatalia useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT khanayesha useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT bowdenjack useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT buchananvanessa useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT odwyermichael useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT cookgordon useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma
AT walshcathal useofsinglearmedobservationaldatatoclosingthegapinotherwisedisconnectedevidencenetworksanetworkmetaanalysisinmultiplemyeloma